Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer

Stock Information for CV Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CV Sciences Inc.

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU 
EDAP to Present at Piper Sandler 37th Annual Healthcare Conference
EDAP Reports Third Quarter 2025 Financial Results
EDAP to Present at Jefferies Global Healthcare Conference in London
EDAP to Participate in the UBS Global Healthcare Conference
EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025
EDAP Secures Euro36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU
Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.